US americans are already spending the money that funds that R&D. One possible solution that occurs to me just now (and is therefore very half baked) is that there must be a way they could continue to spend that money to fund research, while also having a functioning medical safety net
I could have been fully remote, but I wanted to be in the office most days because I liked the routine and liked talking to the people who did want to come in. And my commute was short.
I would have to zoom most people on my team for meetings anyway because they live all over the world. (This is, btw, a good thing: it means we had people working on the project 24/7, each with access to different resources. I was online with the video team and could ping them with any questions, my teammate +8 hours away was online with the majority of infra folks and could get extra support with deployments. etc)
If you have to zoom people anyway, why would it matter whether they live near you and decided to stay home, or live on another continent?
I got both benefits of:
1. Getting to be social in person with other likeminded people
and 2. Having happier teammates who didn't have to sacrifice 3 hours every day commuting and were that much more alert and efficient for it.
>"The overall incidence of myopericarditis from 22 studies (405 272 721 vaccine doses) was 33·3 cases (95% CI 15·3–72·6) per million vaccine doses, and did not differ significantly between people who received COVID-19 vaccines (18·2 [10·9–30·3], 11 studies [395 361 933 doses], high certainty) and those who received non-COVID-19 vaccines (56·0 [10·7–293·7], 11 studies [9 910 788 doses], moderate certainty, p=0·20). Compared with COVID-19 vaccination, the incidence of myopericarditis was significantly higher following smallpox vaccinations (132·1 [81·3–214·6], p<0·0001) but was not significantly different after influenza vaccinations (1·3 [0·0–884·1], p=0·43) or in studies reporting on various other non-smallpox vaccinations (57·0 [1·1–3036·6], p=0·58). Among people who received COVID-19 vaccines, the incidence of myopericarditis was significantly higher in males (vs females), in people younger than 30 years (vs 30 years or older), after receiving an mRNA vaccine (vs non-mRNA vaccine), and after a second dose of vaccine (vs a first or third dose)."
the big ones are also global companies who operate in many countries (and cooperate with many countries' law enforcement).
For me, the better metaphor is to think of them as virtual governments of virtual territories
The science done in the article is fine science. Drawing parallels between the models is good and not woo
The question that started this thread is:
>Aren't quantum effects supposed to disappear in the macroscopic world
Which is just a straightforward misreading of the article.
Nobody is trying to "supress an actual scientific discovery" they are trying to clarify what has actually been discovered.